The miRNA profiling in PANC-1, PANC-1 GEM 100 and PANC-1 GEM1500 cells

ABSTRACT: Gemcitabine has been a first-line therapeutic agent for pancreatic ductal adenocarcinoma (PDAC) pancreatic cancer; however, acquisition of resistance to gemcitabine remains a major challenge. We analyzed miRNAs expression profiles by array-based miRNAs analysis between gemcitabine–resistant (PANC-1/GEM) and parental PANC-1 cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE79234 | GEO | 2016/12/31

SECONDARY ACCESSION(S): PRJNA315249

REPOSITORIES: GEO